Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma


Background and hypothesis Current cancer therapies rely on nonspecific chemotherapies which cause severe side effects without combating relapse. Therapeutic cancer vaccines aim to harness the adaptive immune response to specifically target and eliminate established tumors, while generating durable tumorspecific T cell responses to prevent relapse. Toll like… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.